demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
chloroquine and derivatives
hydroxychloroquine Coalition Covid-19 Brazil I ... FACCT Trial

8 studies excluded by filtering options 0

4824 HC-nCoV (Shanghai), 2020 113high risk of bias
4864 Zhaowei Chen, 2020 113high risk of bias
5517 Min, 2020 1130not a RCTrisk of bias not avaialble
5863 NCT04342650, 2020 110risk of bias not avaialble
5866 NCT04333654, 2020 110risk of bias not avaialble
6697 Thakar, 2021 210excludedrisk of bias not avaialble
6799 Dubee, 2021 000selection pending
7018 Kamran, 2020 113high risk of bias